Cibc World Market Inc. Incyte Corp Transaction History

Cibc World Market Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$85.07 - $109.69 $661,844 - $853,388	-7,780 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$74.18 - $108.93 $244,423 - $358,924	3,295 Added 73.47%	7,780 $809,000
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $8,339 - $11,348	-132 Reduced 2.86%	4,485 $328,000
Q4 2019 Feb 13, 2020	SELL	$73.04 - $95.72 $2,921 - $3,828	-40 Reduced 0.86%	4,617 $403,000
Q3 2019 Nov 13, 2019	SELL	$72.82 - $86.52 $125,541 - $149,160	-1,724 Reduced 27.02%	4,657 $346,000
Q2 2019 Aug 08, 2019	SELL	$73.52 - $88.7 $3.08 Million - $3.71 Million	-41,857 Reduced 86.77%	6,381 $542,000
Q1 2019 May 09, 2019	BUY	$63.56 - $88.17 $3.07 Million - $4.25 Million	48,238 New	48,238 $4.15 Million
Q4 2018 Feb 13, 2019	SELL	$58.5 - $69.94 $817,947 - $977,901	-13,982 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$61.75 - $74.23 $101,702 - $122,256	1,647 Added 13.35%	13,982 $966,000
Q2 2018 Aug 08, 2018	BUY	$60.85 - $83.98 $432,035 - $596,258	7,100 Added 135.63%	12,335 $826,000
Q1 2018 May 18, 2018	BUY	$83.06 - $100.98 $434,819 - $528,630	5,235 New	5,235 $436,000

643

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

Stay updated on Cibc World Market Inc. with notifications on news.